Treatment allocation in controlled trials: why randomise?
暂无分享,去创建一个
[1] J. Elwood,et al. POSSIBLE PREVENTION OF NEURAL-TUBE DEFECTS BY PERICONCEPTIONAL VITAMIN SUPPLEMENTATION , 1980, The Lancet.
[2] I. Olkin,et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.
[3] N. Black. Why we need observational studies to evaluate the effectiveness of health care , 1996, BMJ.
[4] I. Olkin,et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.
[5] M. Daniels. Streptomycin treatment of pulmonary tuberculosis. , 1949, Medical times.
[6] T C Chalmers,et al. Randomized versus historical controls for clinical trials. , 1982, The American journal of medicine.
[7] M. Gnant,et al. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study , 1991, The Lancet.
[8] N. D’Esopo,et al. STREPTOMYCIN TREATMENT OF PULMONARY TUBERCULOSIS , 1998, The Journal of clinical investigation.
[9] Prevention of neural tube defects: Results of the Medical Research Council vitamin study , 1991 .